Hims stock gains as FDA reviews peptides, Voyager secures NASA contract

Market Catalysts Host Julie Hyman and Yahoo Finance Senior Reporter Brooke DiPalma track several of the day's top trending stock tickers, including Hims & Hers Health's (HIMS) stock reaction to US Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr.'s plans to loosen peptide restrictions, Charles Schwab (SCHW) reporting a 30% jump in profits, and Voyager Technologies (VOYG) securing a contract with NASA for a private International Space Station (ISS) mission.